Aarti Industries, Aditya Birla Fashion Retail, Granules India, Hindustan Copper, Manappuram Finance are banned from F&O trading on 13 November 2024.

Indian shares will likely open little changed on Wednesday after a rise in October retail inflation dampened hopes of a rate ...

Aurobindo Pharma: The company arm received a GMP certificate from the European Medicines Agency for Biosimilars Manufacturing ...

Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has received a GMP certificate from the European Medicines Agency for its ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

The fact that the European Medicines Agency (EMA) advised against conditional approval adds to the cautious approach. Moreover, Agenus’s ongoing investigator-sponsored trials (ISTs) in the neoadjuvant ...

* For an explanation of our use of non-GAAP financial measures refer to the "Use of Non-GAAP Financial Measures" section ...

In June 2024, the company announced that it had completed dosing of the first cohort of patients in its phase 1/2 EVENEW ...

Iovance Biotherapeutics' strong Q3 earnings and promising drug pipeline suggest growth potential for risk-tolerant investors.

Global health is likely to be radically altered with Donald Trump in the White House. For starters, the president-elect has ...

If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.